A Case Study in Intra-abdominal Sepsis

Surgical Clinics of North America

Volumn 92, Issue 6, 2012, Pages 1661-1677

  Paul, Jasmeet S ^a   Ridolfi, Timothy J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Diverticulitis; Intra abdominal infections; Management; Reconstruction; Sepsis

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AZTREONAM; CEFAZOLIN; CEFEPIME; CEFOTAXIME; CEFOTETAN; CEFOXITIN; CEFTAZIDIME; CEFTIZOXIME; CEFTRIAXONE; CEPHALOSPORIN; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CORTICOSTEROID; DROTRECOGIN; GATIFLOXACIN; GENTAMICIN; HYPERTENSIVE FACTOR; LEVOFLOXACIN; MEROPENEM; METRONIDAZOLE; MOXIFLOXACIN; NORADRENALIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; TIMENTIN; TOBRAMYCIN;

ABDOMINAL PAIN; ABDOMINAL TENDERNESS; ABSCESS; ADD ON THERAPY; AGED; ANTIBIOTIC THERAPY; CASE REPORT; CENTRAL VENOUS CATHETERIZATION; CLINICAL PROTOCOL; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; CORTICOSTEROID THERAPY; DAMAGE CONTROL LAPAROTOMY; DIAPHORESIS; DIARRHEA; DISEASE SEVERITY; DIVERTICULITIS; DRUG DOSE TITRATION; EMERGENCY SURGERY; FEMALE; FEVER; FLUID RESUSCITATION; HUMAN; HYPOKALEMIA; HYPOPHOSPHATEMIA; INFECTION CONTROL; INTESTINE ANASTOMOSIS; INTESTINE RESECTION; INTUBATION; LAPAROSCOPIC SURGERY; LAPAROTOMY; LETHARGY; MONOTHERAPY; PATIENT MONITORING; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; REVIEW; SEPTIC SHOCK; UNSPECIFIED SIDE EFFECT;

ANTI-BACTERIAL AGENTS; CLINICAL PROTOCOLS; DIVERTICULITIS; FLUID THERAPY; HUMANS; INTRAABDOMINAL INFECTIONS; LAPAROTOMY; MONITORING, PHYSIOLOGIC; SHOCK, SEPTIC; VASOCONSTRICTOR AGENTS;

EID: 84869110283     PISSN: 00396109     EISSN: 15583171     Source Type: Journal    
DOI: 10.1016/j.suc.2012.08.014     Document Type: Review

References (99)

1. Levy M.M., Fink M.P., Marshall J.C., et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 2003, 29(4):530-538.
2. Dellinger R.P., Levy M.M., Carlet J.M., et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008, 36(1):296-327.
3. Rivers E., Nguyen B., Havstad S., et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345(19):1368-1377.
4. Parrillo J.E. Pathogenetic mechanisms of septic shock. N Engl J Med 1993, 328(20):1471-1477.
5. Sihler K.C., Nathens A.B. Management of severe sepsis in the surgical patient. Surg Clin North Am 2006, 86(6):1457-1481.
6. Human albumin administration in critically ill patients: systematic review of randomised controlled trials. Cochrane Injuries Group Albumin Reviewers. BMJ 1998, 317(7153):235-240.
7. Wilkes M.M., Navickis R.J. Patient survival after human albumin administration. A meta-analysis of randomized, controlled trials. Ann Intern Med 2001, 135(3):149-164.
8. Finfer S., Bellomo R., Boyce N., et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004, 350(22):2247-2256.
9. LeDoux D., Astiz M.E., Carpati C.M., et al. Effects of perfusion pressure on tissue perfusion in septic shock. Crit Care Med 2000, 28(8):2729-2732.
10. Holmes C.L., Walley K.R. Bad medicine: low-dose dopamine in the ICU. Chest 2003, 123(4):1266-1275.
11. Sakr Y., Reinhart K., Vincent J.L., et al. Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study. Crit Care Med 2006, 34(3):589-597.
12. De Backer D., Biston P., Devriendt J., et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 2010, 362(9):779-789.
13. De Backer D., Aldecoa C., Njimi H., et al. Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis. Crit Care Med 2012, 40(3):725-730.
14. Holmes C.L., Patel B.M., Russell J.A., et al. Physiology of vasopressin relevant to management of septic shock. Chest 2001, 120(3):989-1002.
15. Patel B.M., Chittock D.R., Russell J.A., et al. Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 2002, 96(3):576-582.
16. Russell J.A., Walley K.R., Singer J., et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008, 358(9):877-887.
17. Russell J.A. Bench-to-bedside review: vasopressin in the management of septic shock. Crit Care 2011, 15(4):226.
18. da Silva Ramos F.J., Azevedo L.C. Hemodynamic and perfusion end points for volemic resuscitation in sepsis. Shock 2010, 34(Suppl 1):34-39.
19. Varpula M., Tallgren M., Saukkonen K., et al. Hemodynamic variables related to outcome in septic shock. Intensive Care Med 2005, 31(8):1066-1071.
20. Marik P.E., Baram M., Vahid B. Does central venous pressure predict fluid responsiveness? A systematic review of the literature and the tale of seven mares. Chest 2008, 134(1):172-178.
21. Michard F. Changes in arterial pressure during mechanical ventilation. Anesthesiology 2005, 103(2):419-428. [quiz: 449-5].
22. Michard F., Boussat S., Chemla D., et al. Relation between respiratory changes in arterial pulse pressure and fluid responsiveness in septic patients with acute circulatory failure. Am J Respir Crit Care Med 2000, 162(1):134-138.
23. Mayer J., Suttner S. Cardiac output derived from arterial pressure waveform. Curr Opin Anaesthesiol 2009, 22(6):804-808.
24. Nguyen H.B., Rivers E.P., Knoblich B.P., et al. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med 2004, 32(8):1637-1642.
25. Jones A.E., Shapiro N.I., Trzeciak S., et al. Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. JAMA 2010, 303(8):739-746.
26. Zubert S., Funk D.J., Kumar A. Antibiotics in sepsis and septic shock: like everything else in life, timing is everything. Crit Care Med 2010, 38(4):1211-1212.
27. Kumar A., Roberts D., Wood K.E., et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006, 34(6):1589-1596.
28. Gaieski D.F., Mikkelsen M.E., Band R.A., et al. Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department. Crit Care Med 2010, 38(4):1045-1053.
29. Brook I., Frazier E.H. Aerobic and anaerobic microbiology in intra-abdominal infections associated with diverticulitis. J Med Microbiol 2000, 49(9):827-830.
30. Solomkin J.S., Mazuski J.E., Bradley J.S., et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis 2010, 50(2):133-164.
31. Byrnes M.C., Mazuski J.E. Antimicrobial therapy for acute colonic diverticulitis. Surg Infect (Larchmt) 2009, 10(2):143-154.
32. Weigelt J.A. Empiric treatment options in the management of complicated intra-abdominal infections. Cleve Clin J Med 2007, 74(Suppl 4):S29-S37.
33. Jacobs D.O. Clinical practice. Diverticulitis. N Engl J Med 2007, 357(20):2057-2066.
34. Marshall J.C., Maier R.V., Jimenez M., et al. Source control in the management of severe sepsis and septic shock: an evidence-based review. Crit Care Med 2004, 32(Suppl 11):S513-S526.
35. Wacha H., Hau T., Dittmer R., et al. Risk factors associated with intra-abdominal infections: a prospective multicenter study. Peritonitis Study Group. Langenbecks Arch Surg 1999, 384(1):24-32.
36. Lopez N., Kobayashi L., Coimbra R. A Comprehensive review of abdominal infections. World J Emerg Surg 2011, 6:7.
37. Annane D., Sebille V., Charpentier C., et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002, 288(7):862-871.
38. Sprung C.L., Annane D., Keh D., et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008, 358(2):111-124.
39. Bernard G.R., Vincent J.L., Laterre P.F., et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001, 344(10):699-709.
40. Abraham E., Laterre P.F., Garg R., et al. Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. N Engl J Med 2005, 353(13):1332-1341.
41. Ely E.W., Laterre P.F., Angus D.C., et al. Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis. Crit Care Med 2003, 31(1):12-19.
42. Finfer S., Ranieri V.M., Thompson B.T., et al. Design, conduct, analysis and reporting of a multi-national placebo-controlled trial of activated protein C for persistent septic shock. Intensive Care Med 2008, 34(11):1935-1947.
43. Savel R.H., Munro C.L. Evidence-based backlash: the tale of drotrecogin alfa. Am J Crit Care 2012, 21(2):81-83.
44. Rafferty J., Shellito P., Hyman N.H., et al. Practice parameters for sigmoid diverticulitis. Dis Colon Rectum 2006, 49(7):939-944.
45. Hulnick D.H., Megibow A.J., Balthazar E.J., et al. Computed tomography in the evaluation of diverticulitis. Radiology 1984, 152(2):491-495.
46. Werner A., Diehl S.J., Farag-Soliman M., et al. Multi-slice spiral CT in routine diagnosis of suspected acute left-sided colonic diverticulitis: a prospective study of 120 patients. Eur Radiol 2003, 13(12):2596-2603.
47. Hinchey E.J., Schaal P.G., Richards G.K. Treatment of perforated diverticular disease of the colon. Adv Surg 1978, 12:85-109.
48. Kaiser A.M., Jiang J.K., Lake J.P., et al. The management of complicated diverticulitis and the role of computed tomography. Am J Gastroenterol 2005, 100(4):910-917.
49. Ambrosetti P., Grossholz M., Becker C., et al. Computed tomography in acute left colonic diverticulitis. Br J Surg 1997, 84(4):532-534.
50. Mueller M.H., Glatzle J., Kasparek M.S., et al. Long-term outcome of conservative treatment in patients with diverticulitis of the sigmoid colon. Eur J Gastroenterol Hepatol 2005, 17(6):649-654.
51. Brandt D., Gervaz P., Durmishi Y., et al. Percutaneous CT scan-guided drainage vs antibiotherapy alone for Hinchey II diverticulitis: a case-control study. Dis Colon Rectum 2006, 49(10):1533-1538.
52. Alvarez J.A., Baldonedo R.F., Bear I.G., et al. Presentation, management and outcome of acute sigmoid diverticulitis requiring hospitalization. Dig Surg 2007, 24(6):471-476.
53. Shaikh S., Krukowski Z.H. Outcome of a conservative policy for managing acute sigmoid diverticulitis. Br J Surg 2007, 94(7):876-879.
54. Evans J., Kozol R., Frederick W., et al. Does a 48-hour rule predict outcomes in patients with acute sigmoid diverticulitis?. J Gastrointest Surg 2008, 12(3):577-582.
55. Sra H.K., Shipman K., Virk H.S. Does a 48-hour rule predict outcomes in patients with acute sigmoid diverticulitis?. J Gastrointest Surg 2009, 13(10):1892.
56. Rao P.M., Rhea J.T., Novelline R.A., et al. Helical CT with only colonic contrast material for diagnosing diverticulitis: prospective evaluation of 150 patients. AJR Am J Roentgenol 1998, 170(6):1445-1449.
57. Ambrosetti P., Becker C., Terrier F. Colonic diverticulitis: impact of imaging on surgical management -a prospective study of 542 patients. Eur Radiol 2002, 12(5):1145-1149.
58. Siewert B., Tye G., Kruskal J., et al. Impact of CT-guided drainage in the treatment of diverticular abscesses: size matters. AJR Am J Roentgenol 2006, 186(3):680-686.
59. Ambrosetti P., Chautems R., Soravia C., et al. Long-term outcome of mesocolic and pelvic diverticular abscesses of the left colon: a prospective study of 73 cases. Dis Colon Rectum 2005, 48(4):787-791.
60. Ferzoco L.B., Raptopoulos V., Silen W. Acute diverticulitis. N Engl J Med 1998, 338(21):1521-1526.
61. Salem L., Flum D.R. Primary anastomosis or Hartmann's procedure for patients with diverticular peritonitis? A systematic review. Dis Colon Rectum 2004, 47(11):1953-1964.
62. Maggard M.A., Zingmond D., O'Connell J.B., et al. What proportion of patients with an ostomy (for diverticulitis) get reversed?. Am Surg 2004, 70(10):928-931.
63. Nelson R., Singer M. Primary repair for penetrating colon injuries. Cochrane Database Syst Rev 2003, (3). CD002247.
64. Singer M.A., Nelson R.L. Primary repair of penetrating colon injuries: a systematic review. Dis Colon Rectum 2002, 45(12):1579-1587.
65. Constantinides V.A., Heriot A., Remzi F., et al. Operative strategies for diverticular peritonitis: a decision analysis between primary resection and anastomosis versus Hartmann's procedures. Ann Surg 2007, 245(1):94-103.
66. Schilling M.K., Maurer C.A., Kollmar O., et al. Primary vs. secondary anastomosis after sigmoid colon resection for perforated diverticulitis (Hinchey Stage III and IV): a prospective outcome and cost analysis. Dis Colon Rectum 2001, 44(5):699-703. [discussion: 703-5].
67. Breitenstein S., Kraus A., Hahnloser D., et al. Emergency left colon resection for acute perforation: primary anastomosis or Hartmann's procedure? A case-matched control study. World J Surg 2007, 31(11):2117-2124.
68. Bauer V.P. Emergency management of diverticulitis. Clin Colon Rectal Surg 2009, 22(3):161-168.
69. O'Sullivan G.C., Murphy D., O'Brien M.G., et al. Laparoscopic management of generalized peritonitis due to perforated colonic diverticula. Am J Surg 1996, 171(4):432-434.
70. Favuzza J., Friel J.C., Kelly J.J., et al. Benefits of laparoscopic peritoneal lavage for complicated sigmoid diverticulitis. Int J Colorectal Dis 2009, 24(7):797-801.
71. Karoui M., Champault A., Pautrat K., et al. Laparoscopic peritoneal lavage or primary anastomosis with defunctioning stoma for Hinchey 3 complicated diverticulitis: results of a comparative study. Dis Colon Rectum 2009, 52(4):609-615.
72. Myers E., Hurley M., O'Sullivan G.C., et al. Laparoscopic peritoneal lavage for generalized peritonitis due to perforated diverticulitis. Br J Surg 2008, 95(1):97-101.
73. Taylor C.J., Layani L., Ghusn M.A., et al. Perforated diverticulitis managed by laparoscopic lavage. ANZ J Surg 2006, 76(11):962-965.
74. Waibel B.H., Rotondo M.F. Damage control in trauma and abdominal sepsis. Crit Care Med 2010, 38(Suppl 9):S421-S430.
75. Rotondo M.F., Schwab C.W., McGonigal M.D., et al. 'Damage control': an approach for improved survival in exsanguinating penetrating abdominal injury. J Trauma 1993, 35(3):375-382. [discussion: 382-3].
76. Ivatury R.R., Nallathambi M., Rao P.M., et al. Open management of the septic abdomen: therapeutic and prognostic considerations based on APACHE II. Crit Care Med 1989, 17(6):511-517.
77. Asensio J.A., McDuffie L., Petrone P., et al. Reliable variables in the exsanguinated patient which indicate damage control and predict outcome. Am J Surg 2001, 182(6):743-751.
78. Aoki N., Wall M.J., Demsar J., et al. Predictive model for survival at the conclusion of a damage control laparotomy. Am J Surg 2000, 180(6):540-544. [discussion: 544-5].
79. Diaz J.J., Cullinane D.C., Dutton W.D., et al. The management of the open abdomen in trauma and emergency general surgery: part 1-damage control. J Trauma 2010, 68(6):1425-1438.
80. Adkins A.L., Robbins J., Villalba M., et al. Open abdomen management of intra-abdominal sepsis. Am Surg 2004, 70(2):137-140. [discussion: 140].
81. Waibel B.H., Rotondo M.F. Damage control for intra-abdominal sepsis. Surg Clin North Am 2012, 92(2):243-257.
82. Rutherford E.J., Skeete D.A., Brasel K.J. Management of the patient with an open abdomen: techniques in temporary and definitive closure. Curr Probl Surg 2004, 41(10):815-876.
83. Schecter W.P., Ivatury R.R., Rotondo M.F., et al. Open abdomen after trauma and abdominal sepsis: a strategy for management. J Am Coll Surg 2006, 203(3):390-396.
84. Barker D.E., Kaufman H.J., Smith L.A., et al. Vacuum pack technique of temporary abdominal closure: a 7-year experience with 112 patients. J Trauma 2000, 48(2):201-206. [discussion: 206-7].
85. Garner G.B., Ware D.N., Cocanour C.S., et al. Vacuum-assisted wound closure provides early fascial reapproximation in trauma patients with open abdomens. Am J Surg 2001, 182(6):630-638.
86. Miller R.S., Morris J.A., Diaz J.J., et al. Complications after 344 damage-control open celiotomies. J Trauma 2005, 59(6):1365-1371. [discussion: 1371-4].
87. De Waele J.J., Leppaniemi A.K. Temporary abdominal closure techniques. Am Surg 2011, 77(Suppl 1):S46-S50.
88. Wittmann D.H., Aprahamian C., Bergstein J.M. Etappen lavage: advanced diffuse peritonitis managed by planned multiple laparotomies utilizing zippers, slide fastener, and Velcro analogue for temporary abdominal closure. World J Surg 1990, 14(2):218-226.
89. Tieu B.H., Cho S.D., Luem N., et al. The use of the Wittmann Patch facilitates a high rate of fascial closure in severely injured trauma patients and critically ill emergency surgery patients. J Trauma 2008, 65(4):865-870.
90. Weinberg J.A., George R.L., Griffin R.L., et al. Closing the open abdomen: improved success with Wittmann Patch staged abdominal closure. J Trauma 2008, 65(2):345-348.
91. Fantus R.J., Mellett M.M., Kirby J.P. Use of controlled fascial tension and an adhesion-preventing barrier to achieve delayed primary fascial closure in patients managed with an open abdomen. Am J Surg 2006, 192(2):243-247.
92. Cipolla J., Stawicki S.P., Hoff W.S., et al. A proposed algorithm for managing the open abdomen. Am Surg 2005, 71(3):202-207.
93. Koniaris L.G., Hendrickson R.J., Drugas G., et al. Dynamic retention: a technique for closure of the complex abdomen in critically ill patients. Arch Surg 2001, 136(12):1359-1362. [discussion: 1363].
94. Verdam F.J., Dolmans D.E., Loos M.J., et al. Delayed primary closure of the septic open abdomen with a dynamic closure system. World J Surg 2011, 35(10):2348-2355.
95. Burlew C.C., Moore E.E., Biffl W.L., et al. One hundred percent fascial approximation can be achieved in the postinjury open abdomen with a sequential closure protocol. J Trauma Acute Care Surg 2012, 72(1):235-241.
96. Diaz J.J., Dutton W.D., Ott M.M., et al. Eastern association for the surgery of trauma: a review of the management of the open abdomen-part 2 " Management of the open abdomen" J Trauma 2011, 71(2):502-512.
97. Tsuei B.J., Skinner J.C., Bernard A.C., et al. The open peritoneal cavity: etiology correlates with the likelihood of fascial closure. Am Surg 2004, 70(7):652-656.
98. Wondberg D., Larusson H.J., Metzger U., et al. Treatment of the open abdomen with the commercially available vacuum-assisted closure system in patients with abdominal sepsis: low primary closure rate. World J Surg 2008, 32(12):2724-2729.
99. Fabian T.C., Croce M.A., Pritchard F.E., et al. Planned ventral hernia. Staged management for acute abdominal wall defects. Ann Surg 1994, 219(6):643-650. [discussion: 651-3].